KCNN4: Intermediate conductance calcium-activated potassium channel protein 4
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Intermediate conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening.
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Chlorzoxazone | Approved | Intermediate conductance calcium-activated potassium channel protein 4 opener | Opener | — |
| Senicapoc | — | Intermediate conductance calcium-activated potassium channel protein 4 blocker | Blocker | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Dehydrated hereditary stomatocytosis
- 0.72
- Breast carcinoma
- 0.42
- Hereditary disease
- 0.41
- Cystic fibrosis
- 0.39
- Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema
- 0.35
- Luminal A breast carcinoma
- 0.30
- Breast cancer
- 0.18
- Alzheimer disease
- 0.13
- Kartagener Syndrome
- 0.12
- Neoplasm
- 0.12
- Glioblastoma
- 0.11
Drugs and mechanisms are from ChEMBL CHEMBL4305 (CC BY-SA 3.0). Gene name, function (UniProt O15554, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets